AGLITTI, Andrea
 Distribuzione geografica
Continente #
AS - Asia 2.058
NA - Nord America 731
EU - Europa 320
SA - Sud America 82
AF - Africa 14
Continente sconosciuto - Info sul continente non disponibili 2
OC - Oceania 1
Totale 3.208
Nazione #
HK - Hong Kong 1.690
US - Stati Uniti d'America 714
SG - Singapore 170
CN - Cina 91
RU - Federazione Russa 82
IT - Italia 76
BR - Brasile 67
DE - Germania 40
VN - Vietnam 26
GB - Regno Unito 25
DK - Danimarca 24
TR - Turchia 21
IE - Irlanda 20
KR - Corea 15
IN - India 11
UA - Ucraina 11
SE - Svezia 9
FI - Finlandia 8
MX - Messico 8
ZA - Sudafrica 7
JP - Giappone 6
AR - Argentina 5
BD - Bangladesh 5
CA - Canada 5
NL - Olanda 5
PK - Pakistan 5
AT - Austria 4
PL - Polonia 4
VE - Venezuela 4
ES - Italia 3
FR - Francia 3
IQ - Iraq 3
KE - Kenya 3
BN - Brunei Darussalam 2
BO - Bolivia 2
EC - Ecuador 2
EU - Europa 2
LT - Lituania 2
MY - Malesia 2
RO - Romania 2
TW - Taiwan 2
AE - Emirati Arabi Uniti 1
AF - Afghanistan, Repubblica islamica di 1
AL - Albania 1
AU - Australia 1
BS - Bahamas 1
CO - Colombia 1
CR - Costa Rica 1
GA - Gabon 1
GT - Guatemala 1
HN - Honduras 1
ID - Indonesia 1
JO - Giordania 1
LB - Libano 1
ML - Mali 1
NO - Norvegia 1
PH - Filippine 1
PS - Palestinian Territory 1
PY - Paraguay 1
QA - Qatar 1
SA - Arabia Saudita 1
SN - Senegal 1
TG - Togo 1
Totale 3.208
Città #
Hong Kong 1.690
Singapore 97
Chandler 94
Ashburn 81
Princeton 70
Ann Arbor 69
Woodbridge 31
Dallas 30
Jacksonville 26
Beijing 24
Moscow 23
Los Angeles 21
Dublin 20
Izmir 17
Andover 15
Washington 15
New York 13
Nürnberg 13
Wilmington 12
Copenhagen 11
Naples 11
Munich 10
São Paulo 10
Chennai 8
Houston 8
Nanjing 8
The Dalles 8
Johannesburg 7
Salerno 7
Turku 7
Brooklyn 6
Fairfield 6
Hanoi 6
Ho Chi Minh City 6
Santa Clara 6
Chicago 5
Columbus 5
Denver 5
Norwalk 5
Redwood City 5
San Giorgio A Cremano 5
San Jose 5
Tokyo 5
Amsterdam 4
Ankara 4
Frederiksberg 4
Guangzhou 4
Hebei 4
Jinan 4
London 4
Nanchang 4
Phoenix 4
Pontecagnano 4
Saint Petersburg 4
Shanghai 4
Warsaw 4
Bolzano 3
Caxias do Sul 3
Contagem 3
Council Bluffs 3
Falls Church 3
Haiphong 3
Latina 3
Nairobi 3
Poplar 3
Quận Bình Thạnh 3
Rome 3
Toronto 3
Atlanta 2
Baghdad 2
Bandar Seri Begawan 2
Boardman 2
Brasília 2
Caracas 2
Changsha 2
Charlotte 2
Faisalabad 2
Haikou 2
Justo Daract 2
Kuala Lumpur 2
La Paz 2
Mercato San Severino 2
Mexico City 2
Monte San Giovanni Campano 2
Nuremberg 2
Orem 2
Pellezzano 2
Poggiomarino 2
Querétaro 2
Salvador 2
San Diego 2
Seattle 2
Taoyuan District 2
Thái Bình 2
Thái Nguyên 2
Tianjin 2
Aachen 1
Amman 1
Apucarana 1
Arraial do Cabo 1
Totale 2.674
Nome #
Characterisation of asymptomatic patients and efficacy of preventive measures for SARS-CoV-2 infection in a large population of Southern Italy: a cohort study 724
Real-life glecaprevir/pibrentasvir in a large cohort of patients with hepatitis C virus infection: The MISTRAL Study 369
Hepatitis C virus infection in jail: Difficult-to-reach, not to-treat. Results of a point-of-care screening and treatment program 345
Liver biopsy in type 2 diabetes mellitus: Steatohepatitis represents the sole feature of liver damage 303
Efficacy and safety of new direct antiviral agents in HCV infected patients with Diffuse Large B Cell Non-Hodgkin Lymphoma 178
Sustained virological response by direct antiviral agents in HCV leads to an early and significant improvement of liver fibrosis 174
The diagnostic conundrum in non-alcoholic fatty liver disease 172
Efficacy and safety of glecaprevir/pibrentasvir in renally impaired patients with chronic HCV infection 133
Untargeted metabolomics as a diagnostic tool in NAFLD: discrimination of steatosis, steatohepatitis and cirrhosis 119
Vascular endothelial dysfunction in inflammatory bowel diseases: Pharmacological and nonpharmacological targets 97
Real-life effectiveness and safety of Glecaprevir/Pibrentasvir in HCV infected patients with chronic kidney disease 94
Role of Oxidative Stress in Pathophysiology of Nonalcoholic Fatty Liver Disease 84
Viral hepatitis: Milestones, unresolved issues, and future goals 83
Real‐Life Efficacy and Safety of Glecaprevir/Pibrentasvir in HCV Infected Patients with Chronic Kidney Disease 75
NAFLD and extra-hepatic comorbidities: Current evidence on a multi-organ metabolic syndrome 72
High efficacy of direct-acting anti-viral agents in hepatitis C virus-infected cirrhotic patients with successfully treated hepatocellular carcinoma 71
Predictors of hepatocellular carcinoma in HCV cirrhotic patients treated with direct acting antivirals 64
HCV point-of-care screening program and treatment options for people who use drugs in a metropolitan area of Southern Italy 63
Clinical features and comorbidity pattern of HCV infected migrants compared to native patients in care in Italy: A real-life evaluation of the PITER cohort 45
Totale 3.265
Categoria #
all - tutte 9.321
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 9.321


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202170 0 0 0 0 0 8 9 8 13 6 21 5
2021/2022129 4 2 5 0 6 2 4 5 21 11 16 53
2022/2023190 19 14 23 17 16 48 0 16 18 2 12 5
2023/2024146 7 8 17 9 20 40 0 9 6 5 8 17
2024/2025349 2 8 4 10 20 47 73 23 33 30 48 51
2025/20262.074 281 937 568 46 173 69 0 0 0 0 0 0
Totale 3.265